Join ACLA Contact Us Site Map Search      
 
American Clinical Laboratory Association  
Partners in Promoting Health
 
  Printer-friendly Version  
 

Results Newsletter - 2002 Issues

The ACLA Results is available in Adobe Acrobat® PDF format. PDF format allows you to view your form electronically on most computers using the freely available Adobe Acrobat® Reader. The Reader is required to view and print PDF files.

December 2002 - Vol. 9, No. 2 [PDF, 20KB]
In this issue:
  • Message from Dr. Sundwall: This austere fiscal climate likely forebodes the challenges Congress will face as they consider the administration's health policy priorities.
  • CPT: Proposals for five clinical laboratory test codes were considered but only two were approved.
  • ESRD: ACLA met with CMS to discuss a proposed resolution for the payment of ESRD lab services provided during a SNF stay.
  • Federal Affairs: CMS is exploring the possibility of extending the technical component grandfather clause administratively.
  • Short Takes: The effective date by which all affected providers must use the new CMS-approved ABN forms is January 1, 2003.
  • Calendar of Events
November 2002 - Vol. 9, No. 1 [PDF, 25KB]
In this issue:
  • Message from Dr. Sundwall: Just how much can get done with relatively narrow margins of majority in each house remains to be seen.
  • ABN: CMS agreed that if a laboratory receives a signed model-language ABN, the laboratory may submit its claim with the GA modifier indicating that it has a signed ABN on file.
  • ESRD: CMS says that carriers will pay claims using ICD-9 code 585 plus 285.21.
  • FDA: The dialogue at the FDA/IVD Roundtable meeting was open and constructive.
  • Federal Affairs: The Administration has delayed publication of the 2003 physician fee schedule.
  • National Policies Transition Period: ACLA met with CMS to discuss the challenges labs will face during the transition period.
  • Calendar of Events
October 2002 - Vol. 8, No. 12 [PDF, 20KB]
In this issue:
  • Message from Dr. Sundwall: The 107th Congress seems to have accomplished little - understandable given the war against terrorism.
  • CLIAC: Dr. Sundwall attended his first CLIAC meeting in Atlanta GA, as a member of the committee.
  • ESRD: ACLA met with CMS contractor medical directors.
  • FDA: ACLA submitted comments to FDA on their ANPRM for Needle-Bearing Devices.
  • Legislative Update: The bill does not include a freeze or any reduction in payments to laboratories.
  • OSHA: ACLA met with OSHA's Office of Health Enforcement.
  • State Issues: ACLA met with officials of the Wadsworth Center to discuss their proposed regulations governing non-FDA approved tests.
  • Calendar of Events
September 2002 - Vol. 8, No. 11 [PDF, 19KB]
In this issue:
  • Message from Dr. Sundwall: Congress faces a huge backlog of business and it is hard to say at this time just how much they will be able to accomplish.
  • ABN: The effective date of the program memorandum is October 1, 2002.
  • www.labtestsonline.org: If you haven't already visited www.labtestsonline.org, we recommended you do so soon.
  • CMS Lab Payment: ACLA made recommendations on the assignment of payment levels for 12 new CPT codes.
  • Environmental/Occupational Health: COT publsihed final regulations revising transportation requirements for infectious substances.
  • 2003 Physician Fee Schedule: ACLA submitted written comments to CMS on the proposed changes to the Physician Fee Schedule.
  • Calendar of Events
August 2002 - Vol. 8, No. 10 [PDF, 19KB]
In this issue:
  • Message from Dr. Sundwall: Significant Medicare reform will not be considered in what remains of this election year.
  • Billing and Reimbursement: We agreed to seek a CMS meeting to discuss claims processing concerns.
  • CPT: ACLA has been collecting information for the CAP Work Group on Genetic Testing Coding.
  • Environmental/Occupational Health: ACLA submitted comments to CDC on their Proposed Data Collection regarding Notification of Possession of a Select Agent.
  • Legislative Affairs: ACLA has been meeting with Senate staff to discuss our priorities, including the single carrier option.
  • State Issues: ACLA communicated with the California Senate expressing our opposition to legislation related to reporting blood lead testing result.
  • Calendar of Events
July 2002 - Vol. 8, No. 9 [PDF, 19KB]
In this issue:
  • Message from Dr. Sundwall: We will now focus our lobbying efforts on the Seante to make sure any Medicare legislation considered is favorable to the clinical laboratory industry and the beneficiaries we serve.
  • CPT: We reviewed a draft of proposed edits to the NCCI.
  • ESRD:  ACLA and representatives met with CMS officials on June 28, 2002.
  • Legislative Affairs: Labs should receive the full CPT update for years beginning 2003 and beyond.
  • Medicare Cholestrol Screening Benefit: The House passed Medicare bill authorizes coverage for cholesterol and "other blood lipid screening tests."
  • State Issues: ACLA met with Dr. Lawrence Sturman to discuss our concerns with respect to NY's proposed regulations governing assay approval.
  • Calendar of Events
June 2002 - Vol. 8, No. 8 [PDF, 20KB]
In this issue:
  • Message from Dr. Sundwall: We have worked hard as we know many of you have, to educate Congress why labs must have the CPI update this year.
  • CPT: The first step of a process to develop CPT codes for new genetic tests was taken by CAP.
  • ESRD: CMS representatives from the coverage and analysis group agreed to meet with ACLA and its ESRD members on our request.
  • FDA: ACLA sent follow-up letters to Dr. Catherine Zoon and Steven Masiello at the FDA's CBER.
  • Genetic Testing: Rapid growth in genomic medicine seems to be parelled by government interest in oversight and regulation.
  • State Issues: ACLA expressed our opposition to competitive bidding for laboratory services provided under Medi-Cal.
  • Calendar of Events
May 2002 - Vol. 8, No. 7 [PDF, 19KB]
In this issue:
  • Message from Dr. Sundwall: Of most interest to the clinical laboratory industry is the Medicare reform legislation under consideration.
  • Billing and Reimbursement: ACLA will seek a meeting with CMS claims processing staff.
  • FDA: ACLA's FDA Committee met with the Center for Biologics and Evaluation and Research.
  • HIPAA: ACLA filed comments with HHS on the Proposed Rule modifying the HIPAA Privacy Regulation.
  • Summit on New Technology: A group of ACLA representatives met here to discuss issues related to new technology approval.
  • Calendar of Events
April 2002 - Vol. 8, No. 6 [PDF, 18KB]
In this issue:
  • Message from Dr. Sundwall: The battles of the budget are being waged behind scenes between Congress and the Administration.
  • ABN: ACLA filed comments regarding the final version of the new ABN.
  • Billing and Reimbursement: ACLA filed comments with CMS regarding identification and return of overpayments and technical amendments to the Medicare and Medicaid programs.
  • ESRD/Clinical Laboratory Service Open Forum: ACLA expressed strong support for CMS to designate a single Medicare carrier to process clinical laboratory claims for ESRD.
  • HHS Advisory Committee on Regulatory Reform: ACLA filed comments regarding ways to reduce current burdens imposed by existing regulations.
  • Calendar of Events
March 2002 - Vol. 8, No. 5 [PDF, 19KB]
In this issue:
  • Message from Dr. Sundwall: The President's budget proposal spares most providers from "cuts" in Medicare reimbursement.
  • Billing and Reimbursement: The ABN form and instructions have been sent to OMB for final review.
  • CPT: We achieved consensus on most lab issues prior to the CPT Editorial Panel meeting.
  • ESRD: ACLA wrote to CMS concerning possible changes to the 50/50 rule for ESRD laboratory testing.
  • FDA: We discussed the status of FDA's proposed draft guidance related to in-vitro HIV drug genotyping assays.
  • Negotiated Rule Making Implementation: The first phase of implementing "national coverage and administrative policies for clnical diagnostic laboratory tests" is imminent.
  • Calendar of Events
February 2002 - Vol. 8, No. 4 [PDF, 15KB]
In this issue:
  • Message from Dr. Sundwall: Newly elected Board Chair, Kenneth Freeman articulated our priorities for 2002, and charged us to work together to achieve them.
  • CMS: ACLA was invited to participate in a CMS "Open Door" Meeting on January 18.
  • ESRD: The ESRD Committee is drafting a letter to CMS to discuss possible changes in the 50/50 rule.
  • Legal: The Committee filed comments on the CMS notice establishing procedures for public consultation on coding and payment determinations for new clinical lab tests.
  • Calendar of Events
January 2002 - Vol. 8, No. 3 [PDF, 18KB]
In this issue:
  • Message from Dr. Sundwall: ACLA will review and revise our legislative and regulatory goals at our Annual Membership Meeting on January 15.
  • Growing Response to Bioterrorism: The past month has been characterized by multiple efforts to address current and future challenges posed by bioterrorism.
  • ABN Update: The website was amended to include an additional Q&A state that the best practice in this situtation is for the patient to receive any necessary ABN at the physician's office.
  • Billing and Reimbursement: ACLA wrote to CMS in response to a request that we identify our top laboratory claims processing issues.
  • Calendar of Events

2005 Issues
2004 Issue Archive
2003 Issue Archive
2001 Issue Archive

back to top